Immunohistochemical Study of Angiogenic Factors in Endometrium and Endometriosis
article
OA: closed
CC0
⤵ 44 in-corpus citations
AI-generated summary
This study found differences in proliferative activity and angiogenic factors between endometrium and endometriosis, with PCNA and endoglin levels varying between pigmented endometriotic lesions, suggesting a role for angiogenesis in endometriosis pathogenesis.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
The proliferative activity and angiogenic factors of pelvic endometriosis and uterine endometrium and their correlation with different pigmented lesions are important throughout the menstrual cycle. The proliferative activity and/or expression of angiogenic factors appears to be different between endometrium and endometriosis, and also different in each pigmented lesion. Immunohistochemical studies using computerized image analysis have shown that in normal endometrium, the PCNA index shows cyclic variation, but no cyclic change is observed in endometriosis. In the pelvic peritoneum, the PCNA index is higher in red lesions compared to black and white lesions. There is no difference in VEGF expression among different pigmented lesions. However, a cyclic variation of VEGF concentration was found in the peritoneal fluid of patients with endometriosis. As a newly determined angiogenic factor, the number of endoglin-positive cells and the mean endothelial area were higher in red lesions than in black or white lesions. These results suggest that the pathogenesis and activity of endometriosis possibly depends on internal angiogenesis. The cellular activity of endometriotic lesions may not necessarily coincide with the regulation of angiogenesis, and may not be synchronized in each pigmented pelvic lesion of endometriosis. Copyrightz1999S.KargerAG, Basel
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (9)
- Angiogenesis in Endometriosis via openalex
- Expression of estrogen and progesterone receptors in endometrium and peritoneal endometriosis: an immunohistochemical and in situ hybridization study via openalex
- Immunohistochemical analysis of proliferative activity and steroid receptor expression in peritoneal and ovarian endometriosis via openalex
- Revised American Society for Reproductive Medicine classification of endometriosis: 1996 via openalex
- W2092874909 via openalex
- W2122846135 via openalex
- W2140246703 via openalex
- W2580031491 via openalex
- W1985959551 via openalex
Cited by (44)
- The Role of the Microenvironment in Endometriosis: Parallels and Distinctions to Cancer 2022
- Comparison of Endoglin Levels (CD 105) in Women's Menstrual Blood Endometriosis and without Endometriosis 2020
- Altered immune environment in peritoneal endometriotic lesions: relationship to lesion appearance 2020
- Endometriotic lesions 2019
- Basic mechanisms of vascularization in endometriosis and their clinical implications 2018
- Influência de agentes antiangiogênicos (propranolol) em endometriose experimentalmente induzida em ratas 2017
- Relation of peritoneal fluid and serum vascular endothelial growth factor levels to endometriosis stage 2014
- Levels of circulating angiogenic cells are not altered in women with endometriosis 2013
- Endoglin concentration in peritoneal fluid of patients with endometriosis 2013
- Lesion kinetics in a non-human primate model of endometriosis 2012
- Endometrial Stem Cells and Endometriosis 2012
- Assessment of endometrial receptivity 2011
- Lymphatic Vessels in Peritoneal Endometriotic Lesions 2011
- Differentielle Expressionsmuster von MMP-2, MMP-9 und PCNA in verschiedenen Endometriosestadien und Endometriumkarzinomen 2011
- Pathophysiology of Infertility in Endometriosis 2011
- The remedial effect of soluble interleukin-1 receptor type II on endometriosis in the nude mouse model 2010
- Semi-invasive Diagnosis of Endometriosis Doctoral Thesis 2010
- Human uterine stem/progenitor cells: their possible role in uterine physiology and pathology 2010
- Association between genetic polymorphisms in fibroblast growth factor (FGF)1 and FGF2 and risk of endometriosis and adenomyosis in Chinese women 2010
- Expression and Role of Peptides, Proteins and Growth Factors in the Pathogenesis of Endometriosis 2009
- The non-human primate model of endometriosis: research and implications for fecundity 2009
- Effects of the levonorgestrel-releasing intrauterine system on cell proliferation, Fas expression and steroid receptors in endometriosis lesions and normal endometrium 2009
- Stem/progenitor cells and the regeneration potentials in the human uterus 2009
- Expression and role of peptides, proteins and growth factors in the pathogenesis of endometriosis 2009
- Expressão do gene da aromatase (CYP19A1) nas células da granulosa murais luteinizadas de mulheres com endometriose submetidas a técnicas de reprodução assistida 2009
- Increased cell proliferation in experimentally induced endometriosis in rabbits 2009
- Development and evaluation of two mouse models for endometriosis focused on the involvement of the immune system in endometriosis establishment 2008
- Heterogeneous appearance of VEGF (vascular endothelial growth factor) immunopositivity in cyst capsules of endometrioma 2008
- Proliferação e apoptose em endométrio tópico e ectópico de pacientes com endometriose peritoneal, ovariana e de septo reto-vaginal 2007
- Vascular endothelial growth factor concentrations in the serum and peritoneal fluid of women with endometriosis 2007
- Peritoneal fluid and serum levels of hepatocyte growth factor may predict the activity of endometriosis 2006
- Endothelial cell survivin is involved in the growth of ovarian endometriotic cysts. 2006
- A baboon model for endometriosis: implications for fertility 2006
- Combined inhibition of vascular endothelial growth factor (VEGF), fibroblast growth factor and platelet-derived growth factor, but not inhibition of VEGF alone, effectively suppresses angiogenesis and vessel maturation in endometriotic lesions 2005
- Time course of pelvic endometriotic lesion revascularization in a nude mouse model 2005
- FGF-1 and S100A13 possibly contribute to angiogenesis in endometriosis 2005
- Vascular endothelial growth factor A and C gene expression in endometriosis 2004
- Higher activity by opaque endometriotic lesions than nonopaque lesions 2004
- Immunohistochemical analysis of vascular endothelial growth factor cellular expression in ovarian endometriomata 2004
- Immunoexpression of hepatocyte growth factor and c-Met receptor in the eutopic endometrium predicts the activity of ectopic endometrium 2003
- Association of interleukin‐6 and estradiol with hepatocyte growth factor in peritoneal fluid of women with endometriosis 2002
- Association of interleukin-6 and estradiol with hepatocyte growth factor in peritoneal fluid of women with endometriosis 2002
- Expression, production, and secretion of vascular endothelial growth factor and interleukin-6 by granulosa cells is comparable in women with and without endometriosis 2001
- Peritoneal endometriosis: validation of an in-vivo model 2001
Source provenance
- europepmc
- last seen: 2026-06-11T06:19:48.454388+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-05-13T22:10:24.024533+00:00
- unpaywall
- last seen: 2026-06-02T02:00:03.124865+00:00
License: CC0
· commercial use OK